Press-release for stocks related to expected for GLAXF

| 4.69% | O: 5.68% H: 0.77% C: 0.77%
AZNCF | $140.15 -4.19% 560

| 3.09% | O: 3.41% H: 0.0% C: -2.45%
VTRS | $11.11 0.09% 0.09% 3.5M

| -5.84% | O: -0.08% H: 3.47% C: -0.25%
NVS | $92.57 -0.55% 0.0% 910K

| -13.61% | O: -2.04% H: 0.19% C: -1.97%
GSK | $39.27 -0.83% 0.01% 2.2M

| 1.3% | O: 4.04% H: 1.57% C: -3.02%
ABBV | News | $164.66 0.25% -0.15% 4.5M

| 0.15% | O: 0.5% H: 0.07% C: -0.81%
SNY | News | $45.395 -1.55% -1.58% 4.4M

| -9.47% | O: 1.75% H: 0.0% C: 0.0%
PBYI | $4.98 -3.68% -3.82% 290K

| 8.5% | O: -0.1% H: 2.31% C: -1.26%
AZN | $68.36 -0.25% -0.25% 4M

| 1.58% | O: 0.82% H: 0.12% C: -1.64%
AMGN | $262.77 -0.49% -0.49% 2M

| -15.79% | O: 0.44% H: 0.2% C: -0.55%
drug breast expected cancer pipeline therapeutics growth market

Kidney Transplantation Therapeutics Market 2023; USD 643.15 million Growth Expected between 2023 and 2028, Rising prevalence of CKD and renal impairments to boost growth - Technavio
Published: 2024-01-29 (Crawled : 18:00) - prnewswire.com
ALPMF | $9.594 43.47% 2.2K

| -15.47% | O: 1.76% H: 0.0% C: 0.0%
GLAXF | $20.2 -14.18% 510

| 6.51% | O: 2.93% H: 0.0% C: -1.15%
ALPMY | $9.46 -1.11% 500K

Manufacturing

| -19.48% | O: -3.53% H: 3.49% C: 3.4%
NVS | $92.57 -0.55% 0.0% 910K

| -13.77% | O: -0.59% H: 0.49% C: 0.41%
GSK | $39.27 -0.83% 0.01% 2.2M

| 1.38% | O: 0.26% H: 0.13% C: -0.18%
ABBV | News | $164.66 0.25% -0.15% 4.5M

| 0.76% | O: 0.19% H: 0.46% C: 0.43%
SNY | News | $45.395 -1.55% -1.58% 4.4M

| -9.36% | O: 0.12% H: 0.0% C: 0.0%
kidney renal expected million therapeutics growth market

Global Urinary Tract Infection (UTI) Treatment Market is expected to Reach US$ 13,617.4 million by 2034, rising at a 1.9% CAGR- FMI Study
Published: 2024-01-22 (Crawled : 19:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510

| 0.5% | O: -2.34% H: 0.43% C: 0.43%
JNJ | News | $145.74 0.67% 0.0% 9.3M

| -10.5% | O: -1.11% H: 0.0% C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M

| 0.18% | O: -0.76% H: 0.38% C: 0.13%
BMY | $48.3 0.96% -0.1% 11M

| -2.56% | O: 0.22% H: 1.49% C: 0.89%
expected million reach infection treatment global study market

Medical Segment Dominates, Expected to Reach $70.4 Billion by 2030 in the Global Recombinant DNA Technology Market
Published: 2023-11-01 (Crawled : 01:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510

| 12.22% | O: -1.62% H: 0.0% C: 0.0%
SNYNF | News | $92.7 -2.18% 1.4K

| 3.73% | O: 0.94% H: 2.55% C: 2.55%
NVSEF | $93.6375 6.88% 82K

| 2.99% | O: 2.52% H: 0.04% C: 0.04%
NVO | $122.75 -1.43% 0.0% 2.8M

| 28.95% | O: 0.87% H: 0.73% C: 0.28%
NVS | $92.57 -0.55% 0.0% 910K

| -0.53% | O: 0.16% H: 0.7% C: 0.57%
GSK | $39.27 -0.83% 0.01% 2.2M

| 10.92% | O: -4.06% H: 1.9% C: 0.96%
LLY | $745.95 -0.64% -0.1% 1.7M

| 32.11% | O: -2.76% H: 0.0% C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M

| -0.11% | O: 0.18% H: 0.0% C: 0.0%
expected reach global dna medical technology market

Global Paronychia Treatment Market Size Expected to Grow by USD 933.78 Million By 2032, With 7.2% CAGR Rise: Polaris Market Research
Published: 2023-10-13 (Crawled : 14:30) - prnewswire.com
GLAXF | $20.2 -14.18% 510

| 10.26% | O: -1.42% H: 0.0% C: 0.0%
NVS | $92.57 -0.55% 0.0% 910K

| -4.89% | O: -0.55% H: 0.69% C: -0.09%
JNJ | News | $145.74 0.67% 0.0% 9.3M

| -6.93% | O: 0.64% H: 0.0% C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M

| 7.0% | O: -0.3% H: 0.72% C: -0.6%
expected treatment research global market

Drug Delivery Technology Market is expected to reach US$ 143.5 billion by 2033 | Future Market Insights, Inc.
Published: 2023-10-09 (Crawled : 14:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510

| 11.66% | O: 0.41% H: 3.94% C: 3.94%
NVS | $92.57 -0.55% 0.0% 910K

| -4.18% | O: 0.01% H: 0.47% C: 0.45%
GSK | $39.27 -0.83% 0.01% 2.2M

| 8.05% | O: 0.82% H: 0.51% C: 0.41%
drug expected reach technology market

Global Diet Pills Market Research Report 2023: Market is Expected to Reach $ 2.47 Billion in 2027 - Focus on Xenical, Qsymia, Saxenda, Diethylpropion, Liraglutide, and Phentermine
Published: 2023-10-05 (Crawled : 10:00) - prnewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M

| 39.86% | O: -0.08% H: 1.44% C: 1.15%
GSK | $39.27 -0.83% 0.01% 2.2M

| 9.76% | O: -0.39% H: 0.72% C: 0.61%
report expected reach research global market

Global Cancer Vaccine Industry Worth $13.4 Billion by 2030: Use of Nanosensors in Diagnosing Cancer Expected to Create Ample Opportunities for Key Players
Published: 2023-06-27 (Crawled : 10:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510

| 11.2% | O: -1.1% H: 0.0% C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M

| 9.18% | O: -0.91% H: 0.56% C: -0.5%
MRNA S | $102.015 -1.38% -1.4% 1.7M

| -14.09% | O: 0.03% H: 0.37% C: 0.18%
DVAX | $11.35 -0.7% -0.7% 2.2M

| -12.23% | O: 0.08% H: 1.31% C: 0.77%
vaccine expected cancer global

Global Smart Food Market Report: Sector is Expected to Reach $1.1 Billion by 2031 at a CAGR of 9.1%
Published: 2023-05-11 (Crawled : 01:00) - prnewswire.com
SXT | $68.23 0.61% 0.0% 290K

Distribution Services

| -8.73% | O: -0.87% H: 1.32% C: 1.18%
K | $56.54 0.84% 0.0% 1.5M

| -20.52% | O: 0.21% H: 0.07% C: 0.0%
INGR A | $112.33 0.93% 0.0% 240K

Process Industries

| 1.24% | O: -0.35% H: 0.28% C: 0.08%
GSK | $39.27 -0.83% 0.01% 2.2M

| 8.4% | O: -0.88% H: 0.25% C: 0.19%
BCPC | $143.25 -0.38% -0.38% 120K

Process Industries

| 16.33% | O: -0.86% H: 1.35% C: 0.81%
expected food reach global smart market

Global Active Pharmaceutical Ingredients Market Report 2023: Sector is Expected to Reach $386.2 Billion by 2032 at a CAGR of 6.4%
Published: 2023-05-04 (Crawled : 22:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510

| 9.57% | O: 0.05% H: 2.53% C: 1.39%
SNYNF | News | $92.7 -2.18% 1.4K

| -13.77% | O: 2.74% H: 0.0% C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M

| 7.87% | O: -0.63% H: 1.56% C: 1.37%
ABBV | News | $164.66 0.25% -0.15% 4.5M

| 12.08% | O: 0.8% H: 0.57% C: -0.34%
SNY | News | $45.395 -1.55% -1.58% 4.4M

| -16.68% | O: 0.81% H: 0.0% C: 0.0%
active report expected reach global market

The Worldwide Manual Toothbrush Industry is Expected to Reach $8.1 Billion by 2028
Published: 2023-01-17 (Crawled : 13:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510

| 15.99% | O: -0.95% H: 3.65% C: 3.19%
UNLYF | $47.0 1.3% 460

| -5.42% | O: 1.38% H: 0.0% C: 0.0%
UL | $46.85 0.34% -0.09% 5.7M

| -9.23% | O: -0.68% H: 0.53% C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M

| 11.93% | O: 0.31% H: 0.62% C: 0.2%
expected

Mersana Therapeutics Provides Business Update and Announces Strategic Objectives and Expected Milestones
Published: 2023-01-06 (Crawled : 12:20) - globenewswire.com
GSK | $39.27 -0.83% 0.01% 2.2M

| 14.85% | O: -0.44% H: 1.85% C: 1.72%
MRSN | $3.34 -5.11% -5.39% 1.3M

| -33.21% | O: 1.33% H: 5.9% C: 3.93%
expected therapeutics update

The Global Addison's Disease Therapeutics Market is expected to grow by $442 mn from 2023-2027, accelerating at a CAGR of 6.93% during the forecast period
Published: 2022-11-30 (Crawled : 16:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510

| 21.18% | O: -0.06% H: 0.06% C: -1.08%
NVSEF | $93.6375 6.88% 82K

| 28.71% | O: 1.83% H: 0.0% C: 0.0%
NVS | $92.57 -0.55% 0.0% 910K

| 6.55% | O: 1.22% H: 1.37% C: 1.28%
GSK | $39.27 -0.83% 0.01% 2.2M

| 15.25% | O: 0.09% H: 0.58% C: 0.58%
ABT | News | $105.27 -0.6% -0.15% 7.3M

| 1.33% | O: 0.12% H: 2.44% C: 2.33%
BIIB | $190.55 -0.84% -0.84% 1.5M

| -33.03% | O: 5.1% H: 1.83% C: -0.36%
AMGN | $262.77 -0.49% -0.49% 2M

| -6.05% | O: 0.2% H: 1.91% C: 1.36%
global disease expected therapeutics market

The Global Migraine Drugs Market is expected to grow by $1 bn during 2022-2026, accelerating at a CAGR of 5.74% during the forecast period
Published: 2022-11-21 (Crawled : 16:00) - prnewswire.com
ENDPQ | $0.0006 -50.0% 620K

| -95.92% | O: -1.63% H: 3.73% C: 3.63%
AZNCF | $140.15 -4.19% 560

| 5.79% | O: 3.09% H: 0.0% C: -1.59%
NVS | $92.57 -0.55% 0.0% 910K

| 8.61% | O: 0.74% H: 0.89% C: 0.53%
GSK | $39.27 -0.83% 0.01% 2.2M

| 20.4% | O: 2.04% H: 0.06% C: -0.36%
ABBV | News | $164.66 0.25% -0.15% 4.5M

| 6.57% | O: 0.27% H: 2.08% C: 1.1%
ABT | News | $105.27 -0.6% -0.15% 7.3M

| 2.44% | O: -0.13% H: 1.13% C: 0.14%
SNY | News | $45.395 -1.55% -1.58% 4.4M

| 2.92% | O: 1.02% H: 0.0% C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M

| 4.91% | O: 0.68% H: 0.35% C: -0.12%
AMGN | $262.77 -0.49% -0.49% 2M

| -7.78% | O: 0.63% H: 0.87% C: -0.32%
global expected migraine market

Anticoagulants Market is expected to generate a revenue of USD 56.16 Billion by 2028, Globally, at 10.20% CAGR: Verified Market Research®
Published: 2022-10-06 (Crawled : 14:20) - prnewswire.com
GLAXF | $20.2 -14.18% 510

| 32.59% | O: -2.53% H: 0.0% C: 0.0%
PFE A | $25.39 -0.12% -0.12% 36M

| -42.38% | O: -0.82% H: 0.03% C: -1.53%
JNJ | News | $145.74 0.67% 0.0% 9.3M

| -12.24% | O: -0.3% H: 0.0% C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M

| 30.22% | O: -1.25% H: 0.53% C: -0.1%
BMY | $48.3 0.96% -0.1% 11M

| -32.4% | O: -0.92% H: 0.06% C: -0.78%
SNY | News | $45.395 -1.55% -1.58% 4.4M

| 14.81% | O: -1.63% H: 0.0% C: 0.0%
research expected market

Immunosuppressants Market Size to Grow by USD 6.69 billion with Expected YOY of 5.3% in 2022 - Technavio
Published: 2022-10-04 (Crawled : 04:00) - prnewswire.com
ALPMF | $9.594 43.47% 2.2K

| -25.97% | O: 5.79% H: 0.0% C: 0.0%
SNYNF | News | $92.7 -2.18% 1.4K

| 21.72% | O: 8.97% H: 0.0% C: 0.0%
ALPMY | $9.46 -1.11% 500K

Manufacturing

| -30.25% | O: 1.34% H: 1.11% C: 1.11%
VTRS | $11.11 0.09% 0.09% 3.5M

| 27.52% | O: 0.8% H: 4.78% C: 4.78%
NVS | $92.57 -0.55% 0.0% 910K

| 21.4% | O: 1.37% H: 1.04% C: 0.66%
GSK | $39.27 -0.83% 0.01% 2.2M

| 30.91% | O: 1.59% H: 0.93% C: -0.07%
ABBV | News | $164.66 0.25% -0.15% 4.5M

| 19.4% | O: 0.64% H: 2.52% C: 2.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M

| 17.69% | O: 2.72% H: 0.0% C: 0.0%
expected market

USD 45.37 Mn incremental growth expected in Darier Disease Drugs Market -- Driven by an increase in demand for advanced dermatological diagnosis
Published: 2022-09-29 (Crawled : 03:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510

| 33.95% | O: -3.32% H: 4.73% C: 4.73%
NVSEF | $93.6375 6.88% 82K

| 51.07% | O: 1.87% H: 0.0% C: 0.0%
VTRS | $11.11 0.09% 0.09% 3.5M

| 27.38% | O: -1.26% H: 0.7% C: -0.23%
NVS | $92.57 -0.55% 0.0% 910K

| 21.96% | O: 0.17% H: 1.1% C: 0.16%
GSK | $39.27 -0.83% 0.01% 2.2M

| 34.42% | O: -0.14% H: 0.53% C: -0.2%
BHC | $8.6 -0.69% 0.0% 2.1M

| 17.0% | O: -1.2% H: 0.0% C: -5.83%
ABBV | News | $164.66 0.25% -0.15% 4.5M

| 14.22% | O: 0.17% H: 0.28% C: -1.47%
disease expected dermatological growth market

USD 28.28 Bn growth expected in Vaccines Market -- Driven by increased funding for vaccine development and new vaccine launches
Published: 2022-09-28 (Crawled : 09:00) - prnewswire.com
CMXHF | $172.54 -19.21% 50

| -5.81% | O: -0.61% H: 0.0% C: 0.0%
MTLHY | $29.93 -11.69% 1.1K

| 28.15% | O: 1.63% H: 0.0% C: -0.48%
CSLLY | $87.96 3.3% 45K

| -3.64% | O: -0.43% H: 1.81% C: 1.44%
GLAXF | $20.2 -14.18% 510

| 40.77% | O: 1.05% H: 4.0% C: 4.0%
AZNCF | $140.15 -4.19% 560

| 27.05% | O: 2.35% H: 0.0% C: -0.68%
ALPMY | $9.46 -1.11% 500K

Manufacturing

| -28.81% | O: -1.91% H: 2.64% C: 1.94%
GSK | $39.27 -0.83% 0.01% 2.2M

| 38.17% | O: 1.12% H: 2.14% C: 1.66%
SNY | News | $45.395 -1.55% -1.58% 4.4M

| 21.42% | O: 0.83% H: 0.0% C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M

| 28.22% | O: 0.04% H: 3.14% C: 2.68%
vaccine expected funding growth market

Global Bio-Pharma Market is Expected to reach USD 703.28 Billion by 2027 at 12.5% CAGR, Says Brandessence Market Research
Published: 2022-09-13 (Crawled : 15:20) - prnewswire.com
GLAXF | $20.2 -14.18% 510

| 25.47% | O: -4.5% H: 0.0% C: 0.0%
SNYNF | News | $92.7 -2.18% 1.4K

| 16.59% | O: 1.78% H: 0.0% C: 0.0%
AZNCF | $140.15 -4.19% 560

| 13.79% | O: -1.22% H: 0.0% C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M

| 22.03% | O: -1.39% H: 0.31% C: -1.16%
ABBV | News | $164.66 0.25% -0.15% 4.5M

| 16.11% | O: -1.19% H: 0.98% C: -1.44%
XERS | $1.77 -0.56% -0.56% 1.1M

| -3.83% | O: -4.92% H: 5.17% C: 2.87%
SNY | News | $45.395 -1.55% -1.58% 4.4M

| 10.11% | O: -0.97% H: 0.16% C: -0.98%
AZN | $68.36 -0.25% -0.25% 4M

| 10.55% | O: -2.2% H: 0.2% C: -2.32%
AMGN | $262.77 -0.49% -0.49% 2M

| 11.5% | O: -0.25% H: 0.05% C: -4.29%
research global expected market

The Rise In Obesity Rates Is Expected To Drive The Weight Loss Supplement Market To $55 Billion By 2026
Published: 2022-08-23 (Crawled : 16:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510

| 17.72% | O: -1.69% H: 0.0% C: 0.0%
K | $56.54 0.84% 0.0% 1.5M

| -25.85% | O: -0.11% H: 1.09% C: 0.86%
GSK | $39.27 -0.83% 0.01% 2.2M

| 16.3% | O: -0.88% H: 0.3% C: -0.06%
obesity expected market

← Previous
1
2
Next →

Gainers vs Losers

64%

36%

Top 10 Gainers

AGBA | News | $1.02 155.0% 57.94% 120M

Finance

ZCMD | $2.86 108.76% 52.1% 2.3M

Commercial Services

INVO | $1.555 104.6% 51.13% 5M

Professional, Scientific, and T...

ISPC | $0.437 105.16% 49.53% 37M

WLGS | News | $0.92 84.0% 45.65% 1.6M

OST | $0.499 21.38% 45.26% 1.9M

XPON | News | $3.1 60.62% 37.74% 17M

TIRX | $0.7 44.39% 30.74% 58M

BNTC | News | $6.92 44.17% 30.64% 3.5M